Ro60-0213
Ro60-0213 is a research chemical that belongs to the benzodiazepine class of drugs. It is known for its anxiolytic, anticonvulsant, hypnotic, sedative, skeletal muscle relaxant, and amnestic properties.
Chemistry[edit]
Ro60-0213 is a benzodiazepine derivative. Benzodiazepines are a class of drugs that are primarily used for treating anxiety, but they also have other uses such as treating seizures, insomnia, and alcohol withdrawal. Benzodiazepines work by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in sedative, hypnotic (sleep-inducing), anxiolytic (anti-anxiety), anticonvulsant, and muscle relaxant properties.
Pharmacology[edit]
Like other benzodiazepines, Ro60-0213 works by binding to specific sites on the GABAA receptor. This enhances the effects of GABA, a neurotransmitter that inhibits activity in the brain. The increased GABA activity results in the drug's sedative, anxiolytic, anticonvulsant, and muscle relaxant effects.
Uses[edit]
Ro60-0213, like other benzodiazepines, is primarily used in research settings. It is not currently approved for medical use in humans. However, its effects on the GABAA receptor and its anxiolytic, anticonvulsant, hypnotic, sedative, skeletal muscle relaxant, and amnestic properties make it a potentially useful tool in the study of these types of drugs and the conditions they are used to treat.
Safety[edit]
As with all benzodiazepines, use of Ro60-0213 carries risks. These include dependence, withdrawal symptoms, and the potential for overdose. Because it is a research chemical, it is not intended for human consumption, and its safety profile in humans is not well-studied.
See also[edit]
- Benzodiazepine
- Research chemical
- [[GABAA receptor]]
- Anxiolytic
- Anticonvulsant
- Hypnotic
- Sedative
- Skeletal muscle relaxant
- Amnestic
-
Ro60-0213
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
